Home
>
National Drug Code (NDC)
>
PANCREAZE
PANCREAZE - 50458-342-60 - (PANCRELIPASE)
Drug Information of PANCREAZE
| Product NDC: | 50458-342 |
| Proprietary Name: | PANCREAZE |
| Non Proprietary Name: | PANCRELIPASE |
| Active Ingredient(s): | 10500; 25000; 43750 [USP'U]/1; [USP'U]/1; [USP'U]/1 & nbsp; PANCRELIPASE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of PANCREAZE
| Product NDC: | 50458-342 |
| Labeler Name: | Janssen Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022523 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100412 |
Package Information of PANCREAZE
| Package NDC: | 50458-342-60 |
| Package Description: | 1 BOTTLE, GLASS in 1 CARTON (50458-342-60) > 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE, GLASS |
NDC Information of PANCREAZE
| NDC Code | 50458-342-60 |
| Proprietary Name | PANCREAZE |
| Package Description | 1 BOTTLE, GLASS in 1 CARTON (50458-342-60) > 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE, GLASS |
| Product NDC | 50458-342 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | PANCRELIPASE |
| Dosage Form Name | CAPSULE, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20100412 |
| Marketing Category Name | NDA |
| Labeler Name | Janssen Pharmaceuticals, Inc. |
| Substance Name | PANCRELIPASE; PANCRELIPASE; PANCRELIPASE |
| Strength Number | 10500; 25000; 43750 |
| Strength Unit | [USP'U]/1; [USP'U]/1; [USP'U]/1 |
| Pharmaceutical Classes |
